AbstractRho-associated kinase 2 (Rock2) is known to promote tumorigenesis in hepatocellular carcinoma (HCC). CCAAT/enhancer-binding protein delta (CEBPD) functions as a tumor suppressor. In this study, we found that the expression of Rock2 and CEBPD are inversely correlated. Knockdown of Rock2 increased CEBPD expression and inhibited the proliferation of HCC cells in vitro and in vivo. Mechanistically, we found that Rock2 regulates CEBPD expression through the p-GSK3β/β-catenin pathway. Taken together, we identified a novel Rock2–p-GSK3β/β-catenin–CEBPD regulatory circuitry, the dysfunction of which may contribute to the tumorigenic characteristic of HCC
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths around the...
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths around the...
Background: High recurrence and chemoresistance drive the high mortality in hepatocellular carcinoma...
AbstractRho-associated kinase 2 (Rock2) is known to promote tumorigenesis in hepatocellular carcinom...
Conference Theme: New Horizons in Cancer Research Conference: Harnessing Breakthroughs - Targeting C...
Deregulation of Rho family small guanosine triphosphatases has been implicated in human carcinogenes...
AbstractProtocadherin 9 (PCDH9) was found frequently lost in hepatocellular carcinoma (HCC). Here we...
Hepatocellular carcinoma (HCC) is the most common liver cancer and is one of the most prevalent canc...
Background & AimsAberrant chromatin modification is a key feature of hepatocellular carcinoma (HCC),...
The Role of Signaling Pathways during the development of Hepatocellular CarcinomaSusie LeeAbstract:...
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths around the...
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancers and a leading cau...
Rho-associated coiled-coil kinase (ROCK) is a major downstream effector of the small GTPase RhoA. Th...
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancers and a leading cau...
Hepatocellular carcmoma (HCC) is the third most common cause of cancer-related deaths worldwide, wit...
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths around the...
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths around the...
Background: High recurrence and chemoresistance drive the high mortality in hepatocellular carcinoma...
AbstractRho-associated kinase 2 (Rock2) is known to promote tumorigenesis in hepatocellular carcinom...
Conference Theme: New Horizons in Cancer Research Conference: Harnessing Breakthroughs - Targeting C...
Deregulation of Rho family small guanosine triphosphatases has been implicated in human carcinogenes...
AbstractProtocadherin 9 (PCDH9) was found frequently lost in hepatocellular carcinoma (HCC). Here we...
Hepatocellular carcinoma (HCC) is the most common liver cancer and is one of the most prevalent canc...
Background & AimsAberrant chromatin modification is a key feature of hepatocellular carcinoma (HCC),...
The Role of Signaling Pathways during the development of Hepatocellular CarcinomaSusie LeeAbstract:...
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths around the...
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancers and a leading cau...
Rho-associated coiled-coil kinase (ROCK) is a major downstream effector of the small GTPase RhoA. Th...
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancers and a leading cau...
Hepatocellular carcmoma (HCC) is the third most common cause of cancer-related deaths worldwide, wit...
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths around the...
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths around the...
Background: High recurrence and chemoresistance drive the high mortality in hepatocellular carcinoma...